These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2317013)

  • 1. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis.
    Durelli L; Massazza U; Poccardi G; Ferrio MF; Cavallo R; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ann Neurol; 1990 Feb; 27(2):174-80. PubMed ID: 2317013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
    Fujii N; Itoyama Y; Goto I
    Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study.
    Ferrio MF; Durelli L; Massazza U; Cavallo R; Poccardi G; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ital J Neurol Sci; 1991 Dec; 12(6):569-73. PubMed ID: 1783535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
    Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
    J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface phenotypes of lymphoid cells altered in the human myasthenic thymus.
    Machi M; Itoyama Y; Goto I; Kuroiwa Y
    Neurology; 1988 Apr; 38(4):592-6. PubMed ID: 3258415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
    Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis.
    Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Itoyama Y
    J Neuroimmunol; 2005 Oct; 167(1-2):186-9. PubMed ID: 16040133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cell surface antigen, immature thymocyte antigen-1, is involved in the differentiation of murine thymocytes.
    Kishi H; Su DM; Muraguchi A; Watanabe T
    J Immunol; 1995 Jul; 155(2):568-77. PubMed ID: 7608536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in thymopoiesis in myasthenia gravis.
    Kosec D; Lavrnić D; Apostolski S; Leposavić G
    Int J Neurosci; 2005 Feb; 115(2):223-43. PubMed ID: 15764003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
    Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
    J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.
    Aiso S; Yoshida T; Watanabe M; Hibi T; Asakura H; Tsuchiya M; Tsuru S
    J Clin Lab Immunol; 1984 Mar; 13(3):137-9. PubMed ID: 6609240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis.
    Nagane Y; Utsugisawa K; Obara D; Yamagata M; Tohgi H
    Muscle Nerve; 2003 May; 27(5):582-9. PubMed ID: 12707978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.